These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 921001)

  • 1. Lymphocytes' cytotoxicity towards cells of human lymphoblastoid lines in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Skurkovich SV; Skorikova AS; Dubrovina NA; Riabova TV; Eremkina EI; Golodnenkova VN; Klinova EG; Olshanski AJ; Shurlapova NF
    Ann Allergy; 1977 Nov; 39(5):344-50. PubMed ID: 921001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative evaluation of the immunoglobulin-synthesizing function of the peripheral lymphocytes in rheumatoid arthritis, systemic lupus erythematosus and rheumatism].
    Benenson EV; Panov VG; Seĭsenbaev ASh; Sagandykov BB
    Ter Arkh; 1982; 54(6):37-40. PubMed ID: 6810488
    [No Abstract]   [Full Text] [Related]  

  • 3. A possible role of Fas-ligand-mediated "reverse signaling" in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus.
    Telegina E; Reshetnyak T; Moshnikova A; Proussakova O; Zhukova A; Kuznetsova A; Ivanov A; Paltsev M; Beletsky I
    Immunol Lett; 2009 Jan; 122(1):12-7. PubMed ID: 19010354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells.
    Horwitz DA; Juul-Nielsen K
    Clin Exp Immunol; 1977 Dec; 30(3):370-8. PubMed ID: 304786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of interleukin-2 on peripheral lymphocytes and monocytes. III. Proliferative and cytotoxic effects in vitro in patients with systemic erythematosus and progressive polyarthritis].
    Jíra M; Strejcek J; Zavadil Z; Antosová E; Rejholec V
    Cas Lek Cesk; 1988 Dec; 127(52):1609-12. PubMed ID: 3265892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of glucocorticosteroid and cytotoxic therapy on the natural cytotoxicity in rheumatic diseases].
    Aleksandrova EN; Nasonov EL
    Ter Arkh; 1985; 57(8):34-7. PubMed ID: 4071433
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological studies on the nature of anemia in rheumatoid arthritis and leukopenia in systemic lupus erythematosus.
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Ryumachi; 1981; 21 Suppl():51-60. PubMed ID: 7344136
    [No Abstract]   [Full Text] [Related]  

  • 10. Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Jan; 134(1):180-6. PubMed ID: 3964813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte nucleolar activation as a marker of autoimmune disorders. II. Observations in patients with systemic lupus erythematosus and other connective tissue diseases.
    Korcákova L; Pekárek J; Rovenský J; Trnavský K; Lukác J; Haskova V
    Immunology; 1976 Nov; 31(5):803-5. PubMed ID: 992713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased numbers of large granular lymphocytes in the peripheral blood in selected inflammatory rheumatic diseases].
    Rovenský J; Tóth J; Rauová L; Lukác J; Zlnay D
    Vnitr Lek; 1991 Jun; 37(6):572-7. PubMed ID: 1897139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 16. Reactivity of RA and SLE lymphocytes stimulated by anti-Ig antibodies.
    Mellbye OJ; Lindström FD; Eberle BJ; Williams RC
    Clin Exp Immunol; 1973 Oct; 15(2):157-68. PubMed ID: 4586839
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical significance of tubuloreticular structures in circulating lymphocytes of patients with erythematodes].
    Horváth A; Schaff Z; Kramer M; Szepesházi K; Ablonczy E; Bognár A; Király K; Lapis K
    Orv Hetil; 1977 Feb; 118(9):500-3. PubMed ID: 840483
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte function in rheumatic disorders.
    Vaughan JH; Chihara T
    Arch Intern Med; 1975 Oct; 135(10):1324-8. PubMed ID: 1100001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.